Physician profile
George E Abraham
NPI 1184669798
$1,856.00
in general payments reported to CMS, 2019-2025
21 companies · $242 in 2025
The $242 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $434 · 2020: $383 · 2021: $314 · 2022: $221 · 2023: $195 · 2024: $67.26 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $503.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $486.99 | 2019-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $250.10 | 2019-2023 | Shingrix, Trelegy Ellipta |
| Abbvie INC. | $234.81 | 2021-2024 | Vraylar |
| Abbott Laboratories | $162.95 | 2021-2025 | Freestyle Libre 3 |
| Alpha Cognition USA, INC. | $125.13 | 2025 | Zunveyl |
| Astellas Pharma US INC | $95.39 | 2019-2023 | Veozah |
| Amarin Pharma, INC. | $90.28 | 2020-2021 | |
| Astrazeneca Pharmaceuticals Lp | $57.10 | 2019-2025 | Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.14 | 2021 | |
| Mylan Specialty L.P. | $47.99 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $44.49 | 2020 | |
| Lilly USA, LLC | $41.78 | 2019-2022 | |
| Pfizer INC. | $37.65 | 2019 | |
| Insmed, INC. | $27.98 | 2025 | Arikayce |
| Genentech USA, INC. | $23.72 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $16.75 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $16.33 | 2023 | Rexulti |
| United Therapeutics Corporation | $14.61 | 2025 | Tyvaso |
| Novartis Pharmaceuticals Corporation | $14.57 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.24 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Abraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.